Development of a novel 96-microwell assay with high throughput for determination of olmesartan medoxomil in its tablets

Chemistry Central Journal

Volumn 6, Issue 1, 2012, Pages

  Darwish, Ibrahim A ^a   Wani, Tanveer A ^a   Khalil, Nasr Y ^a   Al Shaikh, Abdul Aziz ^a   Al Morshadi, Najm ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Charge transfer reaction; High throughput analysis; Microwell based assay; Olmesartan medoxomil; Spectrophotometry

Indexed keywords

EID: 84855243120     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-6-1     Document Type: Article

References (37)

1. Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000, 355:637-645. 10.1016/S0140-6736(99)10365-9, 10696996.
2. Aulakh GK, Sodhi RK, Singh M. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sci 2007, 81:615-639. 10.1016/j.lfs.2007.06.007, 17692338.
3. Bari PD, Rote AR. RP-LC and HPTLC methods for the determination of olmesartan medoxomil and hydrochlorothiazide in combined tablet dosage forms. Chromatographia 2009, 69:1469-1472. 10.1365/s10337-009-1094-z, 2701495, 19568313.
4. Liu D, Hu P, Matsushima N, Li X, Li L, Jiang J. Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 856:190-197. 10.1016/j.jchromb.2007.05.049, 17602900.
5. Vaidya VV, Roy MN, Yetal SM, Joshi SS, Parekh SA. LC-MS-MS Determination of olmesartan in human plasma. Chromatographia 2008, 67:174-150.
6. Liu D, Jiang J, Wang P, Feng S, Hu P. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:743-748. 10.1016/j.jchromb.2010.01.009, 20153270.
7. Sharma RN, Pancholi SS. RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions. Acta Pharm 2010, 60:13-24. 10.2478/v10007-010-0010-2, 20228038.
8. Chouhan KS, Bhure MV, Hemke AT, Gupta KR, Wadodkar SG. Development of RP-HPLC method for estimation of hydrochlorothiazide and olmesartan medoxomil in pharmaceutical formulation. Res J Pharma Biol Chem Sci 2010, 1:78-84.
9. Sengupta P, Das A, Pal TK. Stability-indicating RP-HPLC method for simultaneous determination of olmesartan medoxamil and pioglitazone in fixed dose combination tablet dosage form. Asian J Chem 2010, 22:6471-6479.
10. Mustafa C, Sacide A. Development of a CZE method for the determination of olmesartan medoxomil in tablets. Chromatographia 2007, 66:929-933.
11. Gorog S. Ultraviolet-visible spectrophotometry in pharmaceutical analysis 1995, Boca Raton, FL: CRC Press.
12. Celebier M, Altinoz S. Determination of olmesartan medoxomil in tablets by uv-vis spectrophotometry. Pharmazie 2007, 62:419-422.
13. Hemke AT, Bhure MV, Chouhan KS, Gupta KR, Wadodkar SG. UV Spectrophotometric determination of hydrochlorothiazide and olmesartan medoxomil in pharmaceutical formulation. E-Journal of Che 2010, 7:1156-1161.
14. Verma PK, Kamboj VK, Ranjan S. Spectrophotometric estimation of olmesartan medoxomil in tablet dosage form with stability studies. Int J ChemTech Res 2010, 2:1129-1134.
15. Caglar S, Onal A. Two simple and rapid spectrophotometric methods for the determination of a new antihypertensive drug olmesartan in tablets. J Anal Chem 2010, 65:239-243.
16. Darwish IA. Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. J AOAC Int 2005, 88:38-45.
17. Darwish IA. Kinetic spectrophotometric assays for determination of trimetazidine dihydrochloride. Anal Chim Acta 2005, 551:222-231.
18. Darwish IA. Analytical study for the charge transfer complexes of losartan potassium. Anal Chim Acta 2005, 549:212-220.
19. Darwish IA, Refaat IH. Spectrophotometric analysis of selective serotonin reuptake inhibitors based on formation of charge-transfer complexes with tetracyanoquinodimethane and chloranilic acid. J AOAC Int 2006, 89:326-333.
20. Darwish IA, Abdel-Wadood HA, Abdel-Latif NA. Validated spectrophotometric and fluorimetric assays for analysis of clozapine in tablets and urine. Annali di Chim 2005, 95:345-356.
21. Fidler AT, Baker EL, Letz RE. Neurobehavioural effects of occupational exposure to organic solvents among construction painters. Br J Ind Med 1987, 44:292-308. 1007827, 3496112.
22. Wennborg H, Bonde JP, Stenbeck M, Olsen J. Adverse reproduction outcomes among employees working in biomedical research laboratories. Scand J Work Environ Health 2002, 28:5-11. 10.5271/sjweh.640, 11871853.
23. Lindbohm ML, Taskinen H, Sallmén M, Hemminki K. Spontaneous abortions among women exposed to organic solvents. Am J Ind Med 1990, 17:449-463. 10.1002/ajim.4700170404, 2327413.
24. Wennborg H, Bodin L, Vainio H, Axelsson G. Pregnancy outcome of personnel in Swedish biomedical research laboratories. J Occup Environ Med 2000, 42:438-446. 10.1097/00043764-200004000-00022, 10774513.
25. Kristensen P, Hilt B, Svendsen K, Grimsrud TK. Incidence of lymphohaematopoietic cancer at a university laboratory: a cluster investigation. Eur J Epidemiol 2008, 23:11-15. 10.1007/s10654-007-9203-5, 17985198.
26. Job P. Ann. Chem. 16 (1936) 97. Advanced Physicochemical Experiments 1964, 54. Oliner and Boyd, Edinburgh, 2.
27. Askal HF. Spectrophotometric study of the charge transfer complexes of some pharmaceutical butyrophenones. Talanta 1997, 44:1749-1755. 10.1016/S0039-9140(97)00043-X, 18966914.
28. Darwish IA, Mahmoud AM, Al-Majed AR. A novel analytical approach for reducing the consumption of organic solvents in the charge transfer-based spectrophotometric analysis: application in the analysis of certain antihypertensive drugs. Acta Pharm 2010, 60:493-501. 10.2478/v10007-010-0035-6, 21169140.
29. Taha A, Rücker G. Utility of pi-acceptors in alkaloid assay. Arch Pharm (Weinheim) 1977, 310:485-494.
30. Saleh GA, Askal HF, Darwish IA, El-Shorbagi AN. Spectroscopic analytical study for the charge-transfer complexation of certain cephalosporins with chloranilic acid. Anal Sci 2003, 19:281-287. 10.2116/analsci.19.281, 12608760.
31. Foster R. Organic charge-transfer complexes. 1969, 470. London, New York, Academic Press.
32. United States Pharmacopeial The United States Pharmacopeia 24, The National Formulary 19 2008, United States Pharmacopeial Convention, Inc., Rockville, United States Pharmacopeial.
33. Rosendorff C, Dubiel R, Xu J, Chavanu KJ. Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy. Am J Cardiol 2009, 3:359-65.
34. Chrysant SG. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension. Expert Rev Cardiovasc Ther 2009, 8:887-95.
35. Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate. Am J Cardiovasc Drugs 2007, 5:361-72.
36. Chrysant SG, Weber MA, Wang AC, Hinman DJ. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Am J Hypertens 2004, 3:252-9.
37. Deppeler HP. Hydrochlorothiazide. Analytical profiles of drug substances 1981, 10:405-441. New York: Academic Press, Florey K.